Small Molecule Rescue of ATXN3 Toxicity in C. elegans via TFEB/HLH-30.
Ontology highlight
ABSTRACT: Spinocerebellar ataxia type 3 (SCA3), also known as Machado-Joseph disease (MJD), is a polyglutamine expansion disease arising from a trinucleotide CAG repeat expansion in exon 10 of the gene ATXN3. There are no effective pharmacological treatments for MJD, thus the identification of new pathogenic mechanisms, and the development of novel therapeutics is urgently needed. In this study, we performed a comprehensive, blind drug screen of 3942 compounds (many FDA approved) and identified small molecules that rescued the motor-deficient phenotype in transgenic ATXN3 Caenorhabditis elegans strain. Out of this screen, five lead compounds restoring motility, protecting against neurodegeneration, and increasing the lifespan in ATXN3-CAG89 mutant worms were identified. These compounds were alfacalc
SUBMITTER: Fardghassemi Y
PROVIDER: S-EPMC8423969 | biostudies-literature | 2021 Apr
REPOSITORIES: biostudies-literature
ACCESS DATA